Parallel
AI NativeAI that lets you focus on care
AI that lets you focus on care
Published Sep 19, 2026
No reliable, directly comparable market share data was found for Parallel specifically. The company appears early-stage (participated in an accelerator and has raised early-stage funding).
Given maturity differences, procurement teams may choose CodaMetrix, Fathom, or AKASA when they require:
| Starting Price | Not publicly disclosed (demo-driven pricing) | Not publicly disclosed (enterprise pricing) | Not publicly disclosed (enterprise pricing) |
| Primary use case | Hospitals seeking agents that perform UI-based automation to operate in legacy software environments | Larger systems pursuing contextual/autonomous coding at scale with established market presence | Organizations pursuing autonomous coding; vendor materials emphasize security certifications and case studies |
| Key Strength | Agent-based automation intended to operate across legacy user interfaces, which can reduce API integration effort in some environments | Established positioning in autonomous coding with visible market presence and published content | Focus on autonomous coding with public security-related announcements and published case-study content |
| Key Weakness | Limited public proof (few independent reviews or public case studies accessible); unclear certification artifacts beyond high-level claims | Integration effort and enterprise adoption complexity can be non-trivial | Pricing not transparent; buyers must validate specialty coverage, error modes, and audit defensibility |
—